Cresco Labs Statistics

Total Valuation

Cresco Labs has a market cap or net worth of 193.42 million. The enterprise value is 617.65 million.

Market Cap	193.42M
Enterprise Value	617.65M

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	335.57M
Shares Outstanding	n/a
Shares Change (YoY)	+4.38%
Shares Change (QoQ)	+0.66%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	329.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.28
PB Ratio	0.52
P/TBV Ratio	n/a
P/FCF Ratio	1.84
P/OCF Ratio	1.53
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.24, with an EV/FCF ratio of 5.89.

EV / Earnings	-7.38
EV / Sales	0.84
EV / EBITDA	3.24
EV / EBIT	6.10
EV / FCF	5.89

Financial Position

The company has a current ratio of 2.75, with a Debt / Equity ratio of 1.72.

Current Ratio	2.75
Quick Ratio	1.77
Debt / Equity	1.72
Debt / EBITDA	3.56
Debt / FCF	6.15
Interest Coverage	1.61

Financial Efficiency

Return on equity (ROE) is -18.52% and return on invested capital (ROIC) is 5.64%.

Return on Equity (ROE)	-18.52%
Return on Assets (ROA)	4.42%
Return on Invested Capital (ROIC)	5.64%
Return on Capital Employed (ROCE)	7.70%
Revenue Per Employee	240,453
Profits Per Employee	-28,854
Employee Count	2,900
Asset Turnover	0.51
Inventory Turnover	3.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.82% in the last 52 weeks. The beta is 1.82, so Cresco Labs's price volatility has been higher than the market average.

Beta (5Y)	1.82
52-Week Price Change	-69.82%
50-Day Moving Average	0.69
200-Day Moving Average	1.08
Relative Strength Index (RSI)	33.53
Average Volume (20 Days)	752,778

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cresco Labs had revenue of 697.32 million and -83.68 million in losses. Loss per share was -0.24.

Revenue	697.32M
Gross Profit	342.38M
Operating Income	96.38M
Pretax Income	-27.48M
Net Income	-83.68M
EBITDA	153.05M
EBIT	96.38M
Loss Per Share	-0.24

Full Income Statement

Balance Sheet

The company has 155.35 million in cash and 645.73 million in debt, giving a net cash position of -490.37 million.

Cash & Cash Equivalents	155.35M
Total Debt	645.73M
Net Cash	-490.37M
Net Cash Per Share	n/a
Equity (Book Value)	375.57M
Book Value Per Share	1.31
Working Capital	197.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 126.47 million and capital expenditures -21.53 million, giving a free cash flow of 104.94 million.

Operating Cash Flow	126.47M
Capital Expenditures	-21.53M
Free Cash Flow	104.94M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 49.10%, with operating and profit margins of 13.82% and -12.00%.

Gross Margin	49.10%
Operating Margin	13.82%
Pretax Margin	-3.94%
Profit Margin	-12.00%
EBITDA Margin	21.95%
EBIT Margin	13.82%
FCF Margin	15.05%

Dividends & Yields

Cresco Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.38%
Shareholder Yield	n/a
Earnings Yield	-43.26%
FCF Yield	54.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cresco Labs has an Altman Z-Score of -0.18. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.18
Piotroski F-Score	n/a